These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6369734)

  • 1. One year continuous run with a totally implantable insulin infusion pump in a human diabetic.
    Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Franetzki M; Prestele K; Mion C
    Trans Am Soc Artif Intern Organs; 1983; 29():709-13. PubMed ID: 6369734
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study.
    Jeandidier N; Pinget M; Keipes M; Louy S; Vetter A; Réville P
    Transplant Proc; 1992 Jun; 24(3):948-9. PubMed ID: 1604678
    [No Abstract]   [Full Text] [Related]  

  • 3. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study.
    Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K
    Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-Year Follow-Up After Insulin Pump Initiation: HbA1c Is Significantly Reduced Without Weight Gain.
    Andersen HU; Hangaard S; Hommel E; Ridderstråle M
    J Diabetes Sci Technol; 2018 Mar; 12(2):535-536. PubMed ID: 28927286
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolic control using a subcutaneous insulin infusion pump: effects 2 years after treatment].
    Goicolea Opacua I; Martínez Castillo A; Santamaría Pelarda E; Sola Sarabia C; Vázquez García JA
    Rev Clin Esp; 1988 Mar; 182(4):200-2. PubMed ID: 3045905
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes.
    Chimenti EM; de la Morena LH; Vaquero PM; Sáez-de-Ibarra L; Domínguez MG; Sánchez LF
    Diabetes Res Clin Pract; 2010 Dec; 90(3):e57-9. PubMed ID: 20855123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic control in labile type I diabetes with conventional insulin therapy, basal bolus insulin therapy using pens and continuous subcutaneous insulin infusion with the pump].
    Biesenbach G; Grafinger P; Kaiser W; Stuby U; Zazgornik J
    Med Klin (Munich); 1988 May; 83(12):398-401. PubMed ID: 3043159
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of type I diabetes mellitus with continuous subcutaneous insulin infusion: indications and quality control].
    Berger M; Chantelau EA; Spraul M
    Verh Dtsch Ges Inn Med; 1989; 95():135-40. PubMed ID: 2603477
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical application of insulin pumps in the management of insulin dependent diabetes.
    Greene SA; Smith MA; Baum JD
    Arch Dis Child; 1983 Aug; 58(8):578-81. PubMed ID: 6351759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable programmable insulin pumps for the treatment of diabetes.
    Waxman K; Turner D; Nguyen ST; Selam JL; Charles MA
    Arch Surg; 1992 Sep; 127(9):1032-6; discussion 1036-7. PubMed ID: 1387526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous intraperitoneal insulin infusion versus subcutaneous insulin therapy in the treatment of type 1 diabetes: effects on glycemic variability.
    van Dijk PR; Groenier KH; DeVries JH; Gans RO; Kleefstra N; Bilo HJ; Logtenberg SJ
    Diabetes Technol Ther; 2015 Jun; 17(6):379-84. PubMed ID: 25856045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia.
    Sulli N; Shashaj B
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):393-9. PubMed ID: 12705364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients.
    Selam JL; Raccah D; Jean-Didier N; Lozano JL; Waxman K; Charles MA
    Diabetes Care; 1992 Jan; 15(1):53-8. PubMed ID: 1737542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Better diabetic control with a 4-dose regime--the insulin pen makes the change easier].
    Johannsson G; Stenström G; Fahl H; Andersson AG; Fors B
    Lakartidningen; 1991 Mar; 88(11):954, 957, 959-60. PubMed ID: 2008146
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensor-augmented insulin-pump therapy in type 1 diabetes.
    Diamant M
    N Engl J Med; 2010 Nov; 363(21):2070; author reply 2071. PubMed ID: 21083396
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diabetes and the insulin pump: functional results after 5 consecutive years of permanent use].
    Mirouze J; Rouault R; Misse P; Millet P; Bordat B; Selam JL; Boudet C
    Bull Soc Ophtalmol Fr; 1989 Mar; 89(3):437-40. PubMed ID: 2598391
    [No Abstract]   [Full Text] [Related]  

  • 18. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of continuous subcutaneous insulin infusion versus basal/bolus insulin injections for treatment of type 1 diabetes in clinical practice.
    Myneni A; Aldasouqi S; Page C; Weller L; Carella M; Gossain VV
    J Diabetes Sci Technol; 2009 Mar; 3(2):403-4. PubMed ID: 20144373
    [No Abstract]   [Full Text] [Related]  

  • 20. Real-world outcomes of insulin pump compared to injection therapy in a population-based sample of children with type 1 diabetes.
    Burckhardt MA; Smith GJ; Cooper MN; Jones TW; Davis EA
    Pediatr Diabetes; 2018 Dec; 19(8):1459-1466. PubMed ID: 30129154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.